Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
4tM0jaxdhN4dNdym